1. Home
  2. CGAU vs AMRX Comparison

CGAU vs AMRX Comparison

Compare CGAU & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centerra Gold Inc.

CGAU

Centerra Gold Inc.

HOLD

Current Price

$16.02

Market Cap

3.9B

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$16.66

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGAU
AMRX
Founded
2002
2002
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
CGAU
AMRX
Price
$16.02
$16.66
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$16.67
$15.60
AVG Volume (30 Days)
1.4M
1.9M
Earning Date
04-29-2026
05-01-2026
Dividend Yield
1.16%
N/A
EPS Growth
N/A
157.89
EPS
N/A
0.19
Revenue
N/A
N/A
Revenue This Year
$25.17
$4.48
Revenue Next Year
$13.62
$7.13
P/E Ratio
$11.74
$84.79
Revenue Growth
N/A
N/A
52 Week Low
$6.71
$7.67
52 Week High
$21.17
$16.61

Technical Indicators

Market Signals
Indicator
CGAU
AMRX
Relative Strength Index (RSI) 44.96 79.21
Support Level $15.07 $12.46
Resistance Level $19.95 N/A
Average True Range (ATR) 0.78 0.60
MACD 0.10 0.19
Stochastic Oscillator 37.80 95.99

Price Performance

Historical Comparison
CGAU
AMRX

About CGAU Centerra Gold Inc.

Centerra Gold Inc is principally focused on operating, developing, exploring and acquiring gold and copper properties in North America, Turkey, and other markets world-wide. The company reportable operating segments are Oksut; Mount Milligan; and Molybdenum. It derives maximum revenue from Mount Milligan segment. Geographically, it operates in Turkey, United States, and Canada.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: